BRKS · Categories · Earnings
BRKS - Earnings announcements
Brooks Automation, Inc. (BRKS) earnings announcements - real-time wire coverage filtered to Earnings only.
Recent Earnings for BRKS
- Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and WebcastCHELMSFORD, Mass., Nov. 7, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, November 14, 2022 at 4:30 p.m. Eastern Time. To participate in the conference call, please dial 800-936-4761 for domestic callers and +1-212-231-2922 for international callers. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:3
- Azenta Life Sciences Reports Results of Third Quarter of Fiscal 2022, Ended June 30, 2022CHELMSFORD, Mass., Aug. 9, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financial results for the third quarter ended June 30, 2022. Quarter Ended Dollars in millions, except per share data June 30, March 31, June 30, Change 2022 2022 2021 Prior Qtr. Prior Yr. Revenue from Continuing Operations $ 133 $ 146 $ 129 (9) % 3 % Life Sciences Products $ 47 $ 54 $ 49 (12) % (3) % Life Sciences Services $ 85 $ 92 $ 80 (7) % 6 % Diluted EPS Continuing Operations $ (0.09) $ (0.02) $ (0.02) nm nm Diluted EPS Total $ (0.13) $ 28.28 $ 0.53 nm nm Non-GAAP Diluted EPS Continuing Operations $ 0.12 $ 0.12 $ 0.10 0 % 14 % Adjusted EBITDA Continuing Operations $ 14 $ 19 $ 19 (29) % (26) % M
- Azenta Announces Agreement to Acquire B Medical SystemsEnhances Azenta's Leadership Position in Cold Chain Solutions and End-to-End Sample Management CHELMSFORD, Mass., Aug. 8, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has entered into a definitive agreement to acquire B Medical Systems S.á r.l and its subsidiaries ("B Medical"), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe. The cash purchase price to be paid at closing will be approximately €410 million. Additional cash consideration, up to €50 million, may be paid upon achievement of certain future performance milestones. The transaction is expected to close in O
- Azenta Reports Preliminary Results for Third Quarter of Fiscal 2022, Ended June 30, 2022 and Announces Earnings Conference Call and WebcastCHELMSFORD, Mass., July 13, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported preliminary results for its third fiscal quarter ended June 30, 2022. The Company expects revenue of approximately $133 million, an increase of 3% compared to the third quarter of fiscal 2021. Year-over-year organic growth is expected to be 6%, after adjusting for approximately 3 percentage points of currency impact. GAAP diluted EPS from continuing operations is expected to be in the range of ($0.13) to ($0.08), driven lower than expected primarily due to income taxes. Non-GAAP diluted EPS is expected to be in the range of $0.08 to $0.12. Revenue for the Services segment is expected to be approximatel
- Azenta Life Sciences Reports Preliminary Results of Second Quarter of Fiscal 2022, Ended March 31, 2022Robust customer demand bolstered by operational execution drives strong second quarter results CHELMSFORD, Mass., May 9, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported preliminary financial results for the second quarter ended March 31, 2022. Summary of Preliminary Results On February 1, 2022, the Company completed the sale of its Semiconductor Automation business. The related gain on the sale and the results of the Semiconductor Automation business are treated as discontinued operations and reflected in total diluted EPS. Due to the complexities of the financial carve-out of the business from the Company's financial results, the Company expects it will require additional
- Azenta Reschedules Fiscal 2022 Second Quarter Earnings Conference Call and WebcastCHELMSFORD, Mass., April 28, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has rescheduled the release of its earnings for the second fiscal quarter of 2022 which ended on March 31, 2022 from Tuesday, May 3, 2022 to Monday, May 9, 2022 after the market closes. The change is due to a delay in completing the quarter-end closing process related to the sale of the Semiconductor Automation business, which closed on February 1, 2022. Azenta currently expects second quarter revenue and non-GAAP EPS to be within the previously issued guidance range. The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, May 9, 2022
- Azenta Life Sciences Announces Fiscal 2022 Second Quarter Earnings Conference Call and WebcastCHELMSFORD, Mass., April 14, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal 2022 second quarter earnings which ended on March 31, 2022 on Tuesday, May 3, 2022 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Tuesday, May 3, 2022 at 4:30 p.m. Eastern Time. To participate in the conference call, please dial 800-926-6194 for domestic callers and +1-212-231-2922 for international callers. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m. ET on May 4, 2022. Ab
- Azenta Life Sciences Reports Results of First Quarter of Fiscal 2022, Ended December 31, 2021CHELMSFORD, Mass., Feb. 8, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financial results for the fiscal quarter ended December 31, 2021. Summary of Results Results of continuing operations reflect the Life Sciences business. Due to the agreement reached in the fourth fiscal quarter of 2021 to divest the semiconductor automation business, the results of the semiconductor automation business are treated as discontinued operations and reflected in total diluted EPS. Quarter Ended Dollars in millions, except per share data December 31, September 30, December 31, Change 2021 2021 2020 Prior Qtr. Prior Yr. Revenue from Continuing Operations $ 140 $ 137 $ 118 2 % 18 % Life Sci
- Azenta Life Sciences Announces Fiscal 2022 First Quarter Earnings Conference Call and WebcastCHELMSFORD, Mass, Jan. 24, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal 2022 first quarter earnings which ended on December 31, 2021 on Tuesday, February 8, 2022 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Tuesday, February 8, 2022 at 4:30 p.m. Eastern Time. To participate in the conference call, please dial 800-584-1012 for domestic callers and +1-212-231-2907 for international callers. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m.
- Brooks Automation Reports Results of Fourth Quarter of Fiscal 2021, Ended September 30, 2021, and Announces Quarterly Cash DividendCHELMSFORD, Mass., Nov. 10, 2021 /PRNewswire/ -- Brooks Automation, Inc. (NASDAQ:BRKS) today reported financial results for the fiscal quarter ended September 30, 2021. Summary of GAAP ResultsResults of continuing operations reflect the Life Sciences business. Due to the announced divestiture in the fourth fiscal quarter of 2021, results of the Semiconductor Automation business are treated as discontinued operations and reflected in total diluted EPS. Quarter Ended Year Ended Dollars in millions, except per share data September 30, September 30, September 30, September 30, 2021 2020 Change 2021 2020 Change Revenue - Continuing Operations $ 137 $ 108 27 % $ 514 $ 389 32 % Diluted EPS - C
- Brooks Automation Announces Fiscal 2021 Fourth Quarter and Year-End Earnings Conference Call and WebcastCHELMSFORD, Mass., Nov. 4, 2021 /PRNewswire/ -- Brooks Automation, Inc. (NASDAQ:BRKS) will announce fiscal 2021 fourth quarter and year-end earnings which ended on September 30, 2021 on Wednesday, November 10, 2021 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Wednesday, November 10, 2021 at 4:30 p.m. Eastern Time. To participate in the conference call, please dial 800-786-1918 for domestic callers and +1-212-231-2907 for international callers. Analysts, investors and members of the media can access the live webcast via the Brooks website at https://brooks.investorroom.com/events. A replay will be availab
- Brooks Automation Announces Agreement To Sell Its Semiconductor Solutions Group Business To Thomas H. Lee PartnersCHELMSFORD, Mass., Sept. 20, 2021 /PRNewswire/ -- Brooks Automation, Inc. (NASDAQ:BRKS) today announced that it has entered into a definitive agreement to sell its Semiconductor Solutions Group business (or "automation business") to Thomas H. Lee Partners, L.P. ("THL") for $3.0 billion in cash. The automation business reported approximately $613 million in revenue in the last twelve months ended June 30, 2021. The purchase price is subject to adjustments for working capital and other items. Brooks anticipates closing of the transaction in the first half of calendar year 2022 upon satisfaction of customary closing conditions and regulatory approvals. Brooks' automation business is a leading
- Brooks Automation Reports Results of Third Quarter of Fiscal 2021, Ended June 30, 2021, and Announces Quarterly Cash DividendCHELMSFORD, Mass., Aug. 5, 2021 /PRNewswire/ -- Brooks Automation, Inc. (NASDAQ:BRKS) today reported financial results for the fiscal quarter ended June 30, 2021. Financial Results Summary Quarter Ended Dollars in millions, except per share data June 30, March 31, June 30, Change vs. 2021 2021 2020 Prior Qtr Prior Year Revenue $ 315 $ 287 $ 220 10 % 43 % Semiconductor Solutions $ 186 $ 157 $ 127 19 % 47 % Life Sciences $ 129 $ 130 $ 93 0 % 38 % Diluted EPS Continuing Operations $ 0.53 $ 0.32 $ 0.19 64 % 184 % Diluted EPS Total $ 0.53 $ 0.32 $ 0.19 65 % 184 % Non-GAAP Diluted EPS Continuing Operations $ 0.72 $ 0.61 $ 0.32 17 % 127 % Adjusted EBITDA $ 78 $ 71 $ 40 10 % 94 % Management Com